[1]
|
Memon, N., Weinberger, B.I., Hegyi, T., et al. (2016) Inherited Disorders of Bilirubin Clearance. Pediatric Research, 79, 378-386. https://doi.org/10.1038/pr.2015.247
|
[2]
|
Zhang, M., Wang, H., Huang, Y., et al. (2021) Compound Het-erozygous UGT1A1*28 and UGT1A1*6 or Single Homozygous UGT1A1*28 Are Major Genotypes Associated with Gilbert’s Syndrome in Chinese Han People. Gene, 781, Article ID: 145526. https://doi.org/10.1016/j.gene.2021.145526
|
[3]
|
Maruo, Y., Nakahara, S., Yanagi, T., et al. (2016) Genotype of UGT1A1 and Phenotype Correlation between Crigler-Najjar Syndrome Type II and Gilbert Syndrome. Journal of Gas-troenterology and Hepatology, 31, 403-408.
https://doi.org/10.1111/jgh.13071
|
[4]
|
邓玉婷, 魏民华, 周俊英. Gilbert综合征研究进展[J]. 实用肝脏病杂志, 2021, 24(2): 156-159.
|
[5]
|
Mi, X.X., Yan, J., Ma, X.J., et al. (2019) Analysis of the UGT1A1 Genotype in Hyperbili-rubinemia Patients: Differences in Allele Frequency and Distribution. BioMed Research International, 2019, Article ID: 6272174.
https://doi.org/10.1155/2019/6272174
|
[6]
|
Kamal, S., Abdelhakam, S., Ghoraba, D., et al. (2019) The Frequency, Clinical Course, and Health Related Quality of Life in Adults with Gilbert’s Syndrome: A Longitudinal Study. BMC Gastroenterology, 19, Article No. 22.
https://doi.org/10.1186/s12876-019-0931-2
|
[7]
|
Sun, L., Li, M., Zhang, L., et al. (2017) Differences in UGT1A1 Gene Mutations and Pathological Liver Changes between Chinese Patients with Gilbert Syndrome and Crigler-Najjar Syndrome Type II. Medicine, 96, e8620.
https://doi.org/10.1097/MD.0000000000008620
|
[8]
|
张梦, 齐俊英. UGT1A1基因的分子流行病学及其在Gilbert综合征诊断中的价值[J]. 国际流行病学传染病学杂志, 2019, 46(5): 407-410.
|
[9]
|
向国卿, 孙福荣, 王炳元. 吉尔伯特综合征: 高胆红素血症是敌人还是朋友[J]. 中华肝脏病杂志, 2021, 29(10): 1024-1027.
|
[10]
|
张颖, 金玉. 遗传性非结合性高胆红素血症研究进展[J]. 中国现代医生, 2022, 60(19): 99-102.
|
[11]
|
Maruo, Y., D’Addario, C., Mori, A., et al. (2004) Two Linked Polymorphic Mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the Principal Cause of Gilbert Syndrome. Human Genetics, 115, 525-526.
https://doi.org/10.1007/s00439-004-1183-x
|
[12]
|
Huang, M.J., Chen, Y.C., Huang, Y.Y., et al. (2019) Effect of UDP-Glucuronosyltransferase 1A1 Activity on Risk for Developing Gilbert’s Syndrome. The Kaohsiung Journal of Medical Sciences, 35, 432-439.
https://doi.org/10.1002/kjm2.12077
|
[13]
|
Matsui, K., Maruo, Y., Sato, H., et al. (2010) Combined Effect of Regu-latory Polymorphisms on Transcription of UGT1A1 as a Cause of Gilbert Syndrome. BMC Gastroenterology, 10, Arti-cle No. 57.
https://doi.org/10.1186/1471-230X-10-57
|
[14]
|
梁晨, 罗磊, 白洁. Gilbert综合征和Crigler-Najjar综合征相关尿苷二磷酸葡糖醛酸转移酶A1基因突变位点特征分析[J]. 中华肝脏病杂志, 2020, 28(5): 428-433.
|
[15]
|
鲁杰. 先天性非溶血性黄疸的研究进展[J]. 临床肝胆病杂志, 2021, 37(1): 216-220.
|
[16]
|
Wagner, K.H., Shiels, R.G., Lang, C.A., et al. (2018) Diagnostic Criteria and Contributors to Gilbert’s Syndrome. Critical Reviews in Clinical Laboratory Sciences, 55, 129-139. https://doi.org/10.1080/10408363.2018.1428526
|
[17]
|
张梦, 李维娜, 陈广, 等. UGT1A1基因检测在Gilbert综合征中的诊断价值分析[J]. 中华肝脏病杂志, 2021, 29(2): 143-149.
|
[18]
|
Erlinger, S., Arias, I.M. and Dhumeaux, D. (2014) Inherited Disorders of Bilirubin Transport and Conjugation: New Insights into Molecular Mechanisms and Consequences. Gastroenterology, 146, 1625-1638.
https://doi.org/10.1053/j.gastro.2014.03.047
|
[19]
|
李露锋, 邓国宏, 毛青. Gilbert综合征UGT1A1致病变异的连锁关系研究[J]. 第三军医大学学报, 2020, 42(2): 168-175.
|
[20]
|
Abuduxikuer, K., Fang, L.J., Li, L.T., et al. (2018) UGT1A1 Genotypes and Unconjugated Hyperbilirubinemia Phenotypes in Post-Neonatal Chinese Children: A Retro-spective Analysis and Quantitative Correlation. Medicine (Baltimore), 97, e13576. https://doi.org/10.1097/MD.0000000000013576
|
[21]
|
郭丽萍, 张国淳, 陈博, 等. UGT1A1基因多态性与乳腺癌临床病理特征的相关性[J]. 实用医学杂志, 2020, 36(1): 1-5.
|
[22]
|
Adegoke, O.J., Shu, X.O., Gao, Y.T., et al. (2004) Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 (UGT1A1) and Risk of Breast Cancer. Breast Cancer Research and Treatment, 85, 239-245.
https://doi.org/10.1023/B:BREA.0000025419.26423.b8
|
[23]
|
邸晓辉, 许茜, 宋丽雪, 等. 尿苷二磷酸葡萄糖醛酸转移酶1A1和2B7基因多态性与结直肠癌的相关性研究[J]. 解放军药学学报, 2014, 30(4): 292-295.
|
[24]
|
梁晨, 白丽, 郑素军. Gilbert综合征UGT1A1基因突变特征及对肝脏和肝外系统的影响[J]. 临床肝胆病杂志, 2019, 35(7): 1632-1635.
|
[25]
|
Nelson, R.S., Seligson, N.D., Bottiglieri, S., et al. (2021) UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers (Basel), 13, 1566. https://doi.org/10.3390/cancers13071566
|
[26]
|
印亚双, 王培香, 段京莉. 伊立替康致3-4级中性粒细胞减少与UGT1A1基因多态性相关性的Meta分析[J]. 中国药房, 2017, 28(18): 2523-2528.
|
[27]
|
吴燕子, 陈晓燚, 薛源, 等. UGT1A1基因多态性与伊立替康所致不良反应的相关性分析[J]. 药学与临床研究, 2020, 28(1): 24-27.
|
[28]
|
Takano, M. and Sugiyama, T. (2017) UGT1A1 Polymorphisms in Cancer: Impact on Irinotecan Treatment. Pharmacogenomics and Personalized Medicine, 10, 61-68. https://doi.org/10.2147/PGPM.S108656
|
[29]
|
Hulshof, E.C., Deenen, M.J., Guchelaar, H.J., et al. (2020) Pre-Therapeutic UGT1A1 Genotyping to Reduce the Risk of Irinotec-an-Induced Severe Toxicity: Ready for Prime Time. European Journal of Cancer, 141, 9-20.
https://doi.org/10.1016/j.ejca.2020.09.007
|
[30]
|
Lee, J.S., Wang, J., Martin, M., et al. (2011) Genetic Variation in UGT1A1 Typical of Gilbert Syndrome Is Associated with Unconjugated Hyperbilirubinemia in Patients Receiving To-cilizumab. Pharmacogenetics and Genomics, 21, 365-374. https://doi.org/10.1097/FPC.0b013e32834592fe
|
[31]
|
King, D. and Armstrong, M.J. (2019) Overview of Gilbert’s Syndrome. Drug and Therapeutics Bulletin, 57, 27-31.
https://doi.org/10.1136/dtb.2018.000028
|
[32]
|
Mimura, Y., Maruo, Y., Ohta, Y., et al. (2011) Effect of Common Exon Variant (p.P364L) on Drug Glucuronidation by the Human UDP-Glucuronosyltransferase 1 Family. Basic & Clin-ical Pharmacology & Toxicology, 109, 486-493.
https://doi.org/10.1111/j.1742-7843.2011.00754.x
|
[33]
|
方仲蓉, 王伟鹏. 丙泊酚输注综合征[J]. 心血管外科杂志(电子版), 2013, 2(4): 31-36.
|
[34]
|
Bulmer, A.C., Bakrania, B., Du Toit, E.F., et al. (2018) Bilirubin Acts as a Mul-tipotent Guardian of Cardiovascular Integrity: More than Just a Radical Idea. The American Journal of Physiology-Heart and Circulatory Physiology, 315, H429-H447. https://doi.org/10.1152/ajpheart.00417.2017
|